HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Lubenow Selected Research

lepirudin (Refludan)

11/2005Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3.
10/2003Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.
8/2002[Hirudins in the treatment of heparin-induced thrombocytopenia and in thrombosis prophylaxis].
3/2001Recombinant hirudin in clinical practice: focus on lepirudin.
10/2000Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance.
8/2000Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Lubenow Research Topics

Disease

19Thrombocytopenia (Thrombopenia)
09/2010 - 08/2000
6Thrombosis (Thrombus)
12/2009 - 01/2001
6Hemorrhage
11/2005 - 08/2000
2Acute Coronary Syndrome
09/2001 - 03/2001
1Critical Illness (Critically Ill)
12/2020
1COVID-19
12/2020
1Anaphylaxis (Anaphylactic Shock)
10/2003
1Hypersensitivity (Allergy)
10/2003
1Myocardial Infarction
10/2003
1Wounds and Injuries (Trauma)
10/2003
1Neoplasms (Cancer)
09/2001
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
09/2001
1Unstable Angina
03/2001
1Joint Diseases (Joint Disease)
03/2001
1Renal Insufficiency (Renal Failure)
01/2001
1Transfusion Reaction
11/2000

Drug/Important Bio-Agent (IBA)

19Heparin (Liquaemin)FDA LinkGeneric
09/2010 - 08/2000
8AntibodiesIBA
09/2010 - 10/2000
6lepirudin (Refludan)FDA Link
11/2005 - 08/2000
5Pharmaceutical PreparationsIBA
10/2003 - 01/2001
5HirudinsIBA
08/2002 - 08/2000
3Immunoglobulin G (IgG)IBA
08/2007 - 10/2003
2AntithrombinsIBA
10/2003 - 08/2000
2danaparoid (Orgaran)FDA Link
08/2002 - 01/2001
1Factor Xa (Coagulation Factor Xa)IBA
12/2020
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2020
1AntigensIBA
09/2010
1Platelet Factor 4IBA
09/2010
1Immunoglobulin M (IgM)IBA
08/2007
1Immunoglobulin A (IgA)IBA
08/2007
1desirudin (Iprivask)FDA Link
08/2002
1GoldIBA
09/2001
1AutoantibodiesIBA
09/2001
1Platelet Membrane GlycoproteinsIBA
09/2001
1EpitopesIBA
09/2001
1Platelet Membrane Glycoprotein IIbIBA
09/2001
1Glycoproteins (Glycoprotein)IBA
09/2001
1Glucosamine (Dona)IBA
03/2001
1AntidotesIBA
01/2001
1ThrombinFDA Link
08/2000

Therapy/Procedure

4Therapeutics
12/2009 - 09/2001
2Surgical Amputation (Amputations)
11/2005 - 10/2000
1Controlled Hypotension
10/2003
1Platelet Transfusion (Blood Platelet Transfusions)
09/2001
1Extracorporeal Circulation
03/2001
1Cardiopulmonary Bypass (Heart-Lung Bypass)
03/2001
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2001